Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
hypnotic pyrazolopyrimidine |
| gptkbp:approvalYear |
1999
|
| gptkbp:ATCCode |
gptkb:N05CF03
|
| gptkbp:brand |
Sonata
Starnoc |
| gptkbp:CASNumber |
151319-34-5
|
| gptkbp:contraindication |
severe liver impairment
|
| gptkbp:controlledSubstanceSchedule |
Schedule IV (US)
|
| gptkbp:developedBy |
gptkb:Wyeth
|
| gptkbp:eliminationHalfLife |
1 hour
|
| gptkbp:excretion |
urine
|
| gptkbp:hasMolecularFormula |
C17H15N5O
|
| https://www.w3.org/2000/01/rdf-schema#label |
zaleplon
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
GABA-A receptor agonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:proteinBinding |
~60%
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness headache drowsiness |
| gptkbp:usedFor |
insomnia
|
| gptkbp:bfsParent |
gptkb:SONATA
gptkb:Z-drugs gptkb:z-drugs |
| gptkbp:bfsLayer |
7
|